These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21930110)

  • 1. Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: in vitro characteristics and absorption mechanism in rats.
    Zhang Z; Gao F; Bu H; Xiao J; Li Y
    Nanomedicine; 2012 Jul; 8(5):740-7. PubMed ID: 21930110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: Performance and mechanism.
    Gao F; Zhang Z; Bu H; Huang Y; Gao Z; Shen J; Zhao C; Li Y
    J Control Release; 2011 Jan; 149(2):168-74. PubMed ID: 20951749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and Optimization of Candesartan Cilexetil Nano Lipid Carrier: In Vitro and In Vivo Evaluation.
    Paudel A; Ameeduzzafar ; Imam SS; Fazil M; Khan S; Hafeez A; Ahmad FJ; Ali A
    Curr Drug Deliv; 2017; 14(7):1005-1015. PubMed ID: 28034361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
    Jain S; Reddy VA; Arora S; Patel K
    Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of solid oral dosage form incorporating candesartan nanoparticles.
    Nekkanti V; Pillai R; Venkateshwarlu V; Harisudhan T
    Pharm Dev Technol; 2009; 14(3):290-8. PubMed ID: 19235553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candesartan cilexetil loaded nanodelivery systems for improved oral bioavailability.
    Dudhipala N; Veerabrahma K
    Ther Deliv; 2017 Feb; 8(2):79-88. PubMed ID: 28088883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DEVELOPMENT OF SOLID LIPID NANOCARRIERS FOR ORAL DELIVERY OF CANDESERTAN CILEXETIL.
    Ugurlu T; Nalbantoglu A; Sengel-Turk CT
    Acta Pol Pharm; 2016 Nov; 73(6):1631-1638. PubMed ID: 29634119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile salts enhance the intestinal absorption of lipophilic drug loaded lipid nanocarriers: mechanism and effect in rats.
    Zhang Z; Gao F; Jiang S; Chen L; Liu Z; Yu H; Li Y
    Int J Pharm; 2013 Aug; 452(1-2):374-81. PubMed ID: 23694804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral bioavailability and intestinal absorption of candesartan cilexetil: role of naringin as P-glycoprotein inhibitor.
    Gurunath S; Nanjwade BK; Patil PA
    Drug Dev Ind Pharm; 2015 Jan; 41(1):170-6. PubMed ID: 24168234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three dimensional macroporous hydroxyapatite/chitosan foam-supported polymer micelles for enhanced oral delivery of poorly soluble drugs.
    Zhang Y; Dong K; Wang F; Wang H; Wang J; Jiang Z; Diao S
    Colloids Surf B Biointerfaces; 2018 Oct; 170():497-504. PubMed ID: 29960950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corroboration of naringin effects on the intestinal absorption and pharmacokinetic behavior of candesartan cilexetil solid dispersions using in-situ rat models.
    Surampalli G; K Nanjwade B; Patil PA
    Drug Dev Ind Pharm; 2015; 41(7):1057-65. PubMed ID: 24918161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New supersaturating drug delivery system as strategy to improve apparent solubility of candesartan cilexetil in biorelevant medium.
    Pinto JMO; Leão AF; Alves GF; Mendes C; França MT; Fernandes D; Stulzer HK
    Pharm Dev Technol; 2020 Jan; 25(1):89-99. PubMed ID: 31583925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing the Oral Bioavailability of Candesartan Cilexetil Loaded Nanostructured Lipid Carriers: In Vitro Characterization and Absorption in Rats after Oral Administration.
    Anwar W; Dawaba HM; Afouna MI; Samy AM; Rashed MH; Abdelaziz AE
    Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33142816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Self-Nanoemulsifying Drug Delivery System for Enhancing the Oral Bioavailability of Candesartan Cilexetil: Ex Vivo and In Vivo Evaluation.
    AboulFotouh K; Allam AA; El-Badry M; El-Sayed AM
    J Pharm Sci; 2019 Nov; 108(11):3599-3608. PubMed ID: 31348934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applying Different Techniques to Improve the Bioavailability of Candesartan Cilexetil Antihypertensive Drug.
    Aly UF; Sarhan HA; Ali TFS; Sharkawy HAE
    Drug Des Devel Ther; 2020; 14():1851-1865. PubMed ID: 32523332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and in vitro/in vivo performance of self-nanoemulsifying drug delivery systems loaded with candesartan cilexetil.
    AboulFotouh K; Allam AA; El-Badry M; El-Sayed AM
    Eur J Pharm Sci; 2017 Nov; 109():503-513. PubMed ID: 28889028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of mixed niosomes for oral delivery using candesartan cilexetil as a model poorly water-soluble drug.
    Sezgin-Bayindir Z; Antep MN; Yuksel N
    AAPS PharmSciTech; 2015 Feb; 16(1):108-17. PubMed ID: 25204859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of candesartan.
    Gleiter CH; Mörike KE
    Clin Pharmacokinet; 2002; 41(1):7-17. PubMed ID: 11825094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of solubility and permeability of Candesartan cilexetil by using different pharmaceutical interventions.
    Shaikh SM; Avachat AM
    Curr Drug Deliv; 2011 Jul; 8(4):346-53. PubMed ID: 21453263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.